151 related articles for article (PubMed ID: 18084659)
1. PET/CT findings in a multicentric form of Castleman's disease.
Halac M; Ergul N; Sager S; Demir A; Buyukpinarbasli N; Sonmezoglu K
Hell J Nucl Med; 2007; 10(3):172-4. PubMed ID: 18084659
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT appearance of multicentric Castleman's disease mimicking lymphoma.
Elboga U; Narin Y; Urhan M; Sahin E
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):142-4. PubMed ID: 22133346
[TBL] [Abstract][Full Text] [Related]
3. Unicentric and multicentric Castleman's disease.
Enomoto K; Nakamichi I; Hamada K; Inoue A; Higuchi I; Sekimoto M; Mizuki M; Hoshida Y; Kubo T; Aozasa K; Hatazawa J
Br J Radiol; 2007 Jan; 80(949):e24-6. PubMed ID: 17267466
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET appearance of pelvic Castleman's disease.
Murphy SP; Nathan MA; Karwal MW
J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
[TBL] [Abstract][Full Text] [Related]
5. Report of two cases of Castleman's Disease: a case of benign localized disease and a case of fast progressive multicentric disease.
Mura G; Tauceri F; Feri M; Verdecchia GM
Acta Biomed; 2011 Apr; 82(1):77-81. PubMed ID: 22069961
[TBL] [Abstract][Full Text] [Related]
6. [Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient].
Italiano A; Butori C; Verge M; Mouroux J; Thyss A
Rev Med Interne; 2005 Jul; 26(7):597-9. PubMed ID: 15996575
[No Abstract] [Full Text] [Related]
7. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
[TBL] [Abstract][Full Text] [Related]
9. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
11. False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization.
Williams G; Joyce RM; Parker JA
Clin Nucl Med; 2006 Nov; 31(11):731-2. PubMed ID: 17053400
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET and diffusion-weighted MR imaging appearance in retroperitoneal Castleman's disease: a case report.
Oida Y; Shimizu K; Mukai M; Imaizumi T; Nakamura M; Makuuchi H
Clin Imaging; 2008; 32(2):144-6. PubMed ID: 18313580
[TBL] [Abstract][Full Text] [Related]
14. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
15. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
[No Abstract] [Full Text] [Related]
16. [Imaging findings of angiofollicular lymphoid hyperplasia (Castleman's disease)].
Horger M; Bares R; Wiefels J; Schöber W; Müssig K
Rofo; 2007 Oct; 179(10):991-6. PubMed ID: 18240398
[No Abstract] [Full Text] [Related]
17. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.
Lodde M; Lacombe L; Friede J; Morin F; Saourine A; Fradet Y
BJU Int; 2010 Sep; 106(5):658-63. PubMed ID: 20151968
[TBL] [Abstract][Full Text] [Related]
19. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
20. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
